Curcumin is a compound in turmeric. As a natural medicine that can treat a range of diseases (such as tumors, Alzheimer's disease, etc.), curcumin is highly sought after.
But a recent review of curcumin research suggests that this may not be the case. The article, published in the Journal of Medicinal Chemistry, a journal of the American Chemical Society, collects evidence that contradicts most reports, suggesting that the efficacy of curcumin may be limited.
Turmeric has a unique color and taste, making it a common spice in curry and mustard. It is also a traditional Chinese medicine that has been used for centuries. From the early 1990s, scientists began to study the role of its constituent curcumin, which accounts for 3-5% of turmeric. Scientists believe that it may be the main component of turmeric's health effects. There are currently more than 120 clinical trials investigating the health effects of curcumin. In order to gain a deeper understanding of the medical chemistry of curcumin, the research team led by Michael A. Walters and Guido F. Pauli summarized the research on curcumin.
Through a large number of literature research, they found that a large number of relevant literatures provide evidence that curcumin is unstable under physiological conditions and is not easily absorbed by the body. These properties make curcumin difficult to be a drug candidate. In addition, they did not find a double-blind, placebo-controlled clinical trial that supports curcumin as a panacea for disease-enhancing health. But the researchers believe that this does not mean that research on turmeric should be stopped. Turmeric extract does have a certain health effect, although it may not be as effective as it is now. In addition, the researchers believe that future research should use a more comprehensive approach to the various components of turmeric, because these ingredients may work together to play a healthy role in turmeric.